- Home
- IMRN vs MTEX Comparison
IMRN vs MTEX Comparison
Compare IMRN & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- MTEX
- Stock Information
- Founded
- IMRN 1994
- MTEX 1993
- Country
- IMRN Australia
- MTEX United States
- Employees
- IMRN N/A
- MTEX N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- MTEX Medicinal Chemicals and Botanical Products
- Sector
- IMRN Health Care
- MTEX Health Care
- Exchange
- IMRN Nasdaq
- MTEX Nasdaq
- Market Cap
- IMRN 9.2M
- MTEX 20.0M
- IPO Year
- IMRN N/A
- MTEX 1999
- Fundamental
- Price
- IMRN $1.87
- MTEX $8.31
- Analyst Decision
- IMRN Strong Buy
- MTEX
- Analyst Count
- IMRN 1
- MTEX 0
- Target Price
- IMRN $5.00
- MTEX N/A
- AVG Volume (30 Days)
- IMRN 26.3K
- MTEX 19.2K
- Earning Date
- IMRN 09-08-2025
- MTEX 08-12-2025
- Dividend Yield
- IMRN N/A
- MTEX N/A
- EPS Growth
- IMRN N/A
- MTEX N/A
- EPS
- IMRN N/A
- MTEX N/A
- Revenue
- IMRN $4,048,286.00
- MTEX $115,036,000.00
- Revenue This Year
- IMRN N/A
- MTEX N/A
- Revenue Next Year
- IMRN N/A
- MTEX N/A
- P/E Ratio
- IMRN N/A
- MTEX N/A
- Revenue Growth
- IMRN 82.90
- MTEX N/A
- 52 Week Low
- IMRN $1.50
- MTEX $7.00
- 52 Week High
- IMRN $2.87
- MTEX $16.49
- Technical
- Relative Strength Index (RSI)
- IMRN 58.63
- MTEX 39.24
- Support Level
- IMRN $1.70
- MTEX $8.40
- Resistance Level
- IMRN $1.78
- MTEX $9.90
- Average True Range (ATR)
- IMRN 0.10
- MTEX 0.68
- MACD
- IMRN 0.01
- MTEX -0.07
- Stochastic Oscillator
- IMRN 77.50
- MTEX 9.81
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.